INTERNATIONAL PATENT: BOSTON SCIENTIFIC SCIMED, INC. FILES APPLICATION FOR "OXIME-BASED CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS"

GENEVA, July 21 -- BOSTON SCIENTIFIC SCIMED, INC. (One Scimed PlaceMaple Grove, Minnesota 55311) filed a patent application (PCT/US2025/010730) for "OXIME-BASED CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS" on Jan 08, 2025. With publication no. WO/2025/151512, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HSU, Yen-Hao (6 Vega DriveShrewsbury, Massachusetts 01545), KLEINFEHN, Alex (6030 Hemlock Lane NorthUnit 1Plymouth, Minnesota 55442)

Abstract: In some aspects, the present disclosure prov...